You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In PNAS this week: genetic diversity of SARS-CoV-2 indicates neutral evolution, portable RT-LAMP method to detect SARS-CoV-2, and more.
A number of diagnostic labs have considered saliva-based SARS-CoV-2 testing but decided against it, while other groups continue to pursue it.
The company said it is using the technology for synthetic biology, diagnosis of inherited genetic diseases, liquid biopsy, and infectious disease detection.
Scientific American reports on a new way of encoding data in DNA for storage.
In PNAS this week: interactions of coronavirus' EndoU endoribonuclease enzyme, analysis of phylogenetic trees, and more.
A summer program at the University of Illinois at Urbana-Champaign aims to foster partnerships between genetics researchers and indigenous communities, WILL reports.
In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.
A commentary appearing in Nature calls for the establishment of a research policy board in the US.
The program was established to support the development and dissemination of functional genomic tools and techniques for genome manipulation in model organisms.
While "genomical" has not supplanted "astronomical" in the lexicon, geneticist Gene Robinson believes data scientists understand the sheer size of genomic information.
The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.
The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.
Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.
In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.